Uxin Limited (UXIN)
(Delayed Data from NSDQ)
$1.66 USD
+0.05 (3.11%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $1.62 -0.04 (-2.41%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBalance Sheet
Fiscal Year End for Uxin Limited Sponsored ADR falls in the month of March.
All items in Millions except Per Share data.
3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 14 | 22 | 36 | 113 |
Receivables | NA | 2 | 26 | 37 | 48 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 16 | 67 | 11 | 1 |
Other Current Assets | NA | 9 | 23 | 44 | 154 |
Total Current Assets | NA | 41 | 138 | 127 | 316 |
Net Property & Equipment | NA | 9 | 5 | 4 | 12 |
Investments & Advances | NA | 42 | 46 | 44 | 39 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 0 | 0 | 0 | 1 |
Deposits & Other Assets | NA | 0 | 4 | 6 | 0 |
Total Assets | NA | 105 | 197 | 188 | 374 |
Liabilities & Shareholders Equity | 3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 12 | 15 | 15 | 19 |
Current Portion Long-Term Debt | NA | 26 | 53 | 12 | 70 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 0 | 0 | 0 | 0 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 50 | 137 | 146 | 341 |
Total Current Liabilities | NA | 88 | 205 | 175 | 434 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 246 | 237 |
Long-Term Debt | NA | 81 | 129 | 36 | 33 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 110 | 100 | 31 | 0 |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 290 | 436 | 493 | 705 |
Shareholders Equity | 3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 2,250 | 2,249 | 2,090 | 1,841 |
Retained Earnings | NA | -2,468 | -2,532 | -2,428 | -2,187 |
Other Equity | NA | 32 | 45 | 33 | 15 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | -185 | -238 | -305 | -331 |
Total Liabilities & Shareholder's Equity | NA | 105 | 197 | 188 | 374 |
Total Common Equity | 0 | -185 | -238 | -305 | -331 |
Shares Outstanding | 4.70 | 4.70 | 3.90 | 3.70 | 2.90 |
Book Value Per Share | 0.00 | -39.45 | -61.08 | -82.33 | -114.18 |
Fiscal Year End for Uxin Limited Sponsored ADR falls in the month of March.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | -99,999 | 2 | 9 | 14 |
Receivables | NA | NA | 3 | 2 | 2 |
Notes Receivable | NA | NA | 0 | 0 | 0 |
Inventories | NA | NA | 25 | 16 | 16 |
Other Current Assets | NA | NA | 9 | 9 | 9 |
Total Current Assets | NA | NA | 39 | 35 | 41 |
Net Property & Equipment | NA | NA | 10 | 9 | 9 |
Investments & Advances | NA | NA | 40 | 40 | 42 |
Other Non-Current Assets | NA | NA | 0 | 0 | 0 |
Deferred Charges | NA | NA | 0 | 0 | 0 |
Intangibles | NA | NA | 0 | 0 | 0 |
Deposits & Other Assets | NA | NA | 0 | 0 | 0 |
Total Assets | NA | NA | 318 | 100 | 105 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | NA | 0 | 0 | 0 |
Accounts Payable | NA | NA | 11 | 11 | 12 |
Current Portion Long-Term Debt | NA | NA | 7 | 5 | 26 |
Current Portion Capital Leases | NA | NA | 29 | 0 | 0 |
Accrued Expenses | NA | NA | 0 | 0 | 0 |
Income Taxes Payable | NA | NA | 0 | 0 | 0 |
Other Current Liabilities | NA | NA | 53 | 57 | 50 |
Total Current Liabilities | NA | NA | 100 | 73 | 88 |
Mortgages | NA | NA | 0 | 0 | 0 |
Deferred Taxes/Income | NA | NA | 0 | 0 | 0 |
Convertible Debt | NA | NA | 0 | 0 | 0 |
Long-Term Debt | NA | NA | 40 | 40 | 81 |
Non-Current Capital Leases | NA | NA | 186 | 0 | 0 |
Other Non-Current Liabilities | NA | 170 | 159 | 110 | |
Minority Interest (Liabilities) | NA | NA | 0 | 0 | 0 |
Total Liabilities | NA | NA | 509 | 287 | 290 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | NA | 0 | 0 | 0 |
Common Stock (Par) | NA | NA | 0 | 0 | 0 |
Capital Surplus | NA | NA | 2,159 | 2,132 | 2,250 |
Retained Earnings | NA | NA | -2,381 | -2,350 | -2,468 |
Other Equity | NA | NA | 31 | 31 | 32 |
Treasury Stock | NA | NA | 0 | 0 | 0 |
Total Shareholder's Equity | NA | NA | -191 | -186 | -185 |
Total Liabilities & Shareholder's Equity | NA | NA | 318 | 100 | 105 |
Total Common Equity | 0 | 0 | -191 | -186 | -185 |
Shares Outstanding | 4.70 | 4.70 | 4.70 | 4.70 | 4.70 |
Book Value Per Share | 0.00 | 0.00 | -40.67 | -39.66 | -39.45 |